Author(s): Bharambe BM, Deshpande KA, Surase SG, Ajmera AP
Uterine leiomyoma is the most common tumor found in women of reproductive age group. The clinical symptoms and severity usually depend upon the size, position, and number of fibroids present. The incidence of sarcomas in patients operated for leiomyomas is 0.23 % [1], with leiomyosarcoma being rarer estimated to be between 0.13 and 0.29 % [1, 2]. Uterine leiomyosarcoma comprises ~1 % of all uterine malignancies—average age of occurrence being 40–50 years. Metastasis from leiomyosarcoma of uterus occurs mainly to lung, liver, brain, kidney, and bones. Secondaries to ovary from uterine leiomyosarcomas are, however, very rare (3.5 %).
Referred From: https://link.springer.com/article/10.1007/s13224-012-0202-4
Author(s): Hung GY, Horng JL, Chen PC
Author(s): Mayerhofer K, Obermair A, Windbichler G
Author(s): Rotmensch J, Bosnyak S, Montag A
Author(s): Yanai H, Wani Y, Notohara K, Takada S, Yoshino T
Author(s): Winchester DS, Hocker TL, Brewer JD
Author(s): Fields JP, Helwig EB
Author(s): Bernstein SC, Roenigk RK
Author(s): Choi JH, Ro JY
Author(s): Starr GF, Dockerty MB
Author(s): Humphreys TR, Finkelstein DH, Lee JB
Author(s): Rao UN, Finkelstein SD, Jones MW
Author(s): Starling J, Coldiron BM
Author(s): Liao WC, Wang YC, Ma H
Author(s): Zacher M, Heppt MV, Brinker TJ, Hayani KM, Flaig MJ, et al.
Author(s): Svarvar C, Bohling T, Berlin O